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For decades, curcumin (Cur), a natural polyphenol product derived from turmeric (Curcuma longa) has 
been considered one of the most promising bioactive compounds due to its health benefits such as 
anti-inflammatory, antioxidant and anticarcinogenic properties. However, Cur application as functional 
compound in food products has been limited due to light, heat, and oxidation sensitive and mainly, to 
poor aqueous solubility which limit its bioavailability [1]. To increase Cur bioaccessibility and 
consequently, increase bioavailability, several carriers have been investigated, particularly nanocarriers. 
Among the various nanocarriers described in the literature, lipid-based nanocarriers may offer a 
promising tool to increase the stability, efficacy and safety of lipophilic compounds, namely Cur [2]. 
Moreover, the understanding of Cur-loaded nanocarriers’ behaviour under gastrointestinal (GI) 
conditions is fundamental to produce safe and customized nanocarriers with optimized bioactivity for 
oral consumption. 
The aim of this study was to comparatively analyze the impact of two different lipid nanocarriers 
incorporating Cur - solid lipid nanoparticles (SLN) and nanoemulsions (NE) – on bioaccessibility and 
Caco-2 cells viability. 
The evaluation of the Cur-loaded lipid-based nanocarriers was performed based on their 
physicochemical properties and bioaccessibility under in vitro simulated GI conditions (using INFOGEST 
in vitro digestion method). During digestion process, samples were collected at each stage (i.e. mouth, 
stomach and intestine) and nanocarriers’ size, -potential, free fatty acids’ release (FFA) and cur 
bioaccessibility were evaluated. Furthermore, in vitro cell viability of different nanocarriers was analyzed 
in Caco-2 cell line by MTT assay. Caco-2 cells were incubated with free Cur and different nanocarriers 
formulations at CU concentration of 0-25 µg.mL-1 for 24 h. 
The results from the in vitro digestion indicated Cur-loaded SNL and Cur-loaded NE stability under 
simulated mouth and stomach conditions. On the other hand, these nanocarriers were destabilized 
under simulated intestinal conditions; Cur-loaded NE showed less stability because particle size 
increased indicating droplet coalescence. Also, higher amount of FFA was released from NE compared 
to SNL. NE and SLN increased 3.4 and 2.5 times Cur bioaccessibility, respectively. In vitro cell viability 
assay revealed that the highest concentration of Curc on both NE and SLN formulations that one can 
use without interfere with cellular viability was 15 µg.mL-1 after 24 h incubation. 
This study showed the potential of fabricated NE and SLN for oral delivery of Cur, a hydrophobic 




[1] Mahmood, K, Zia, KM, Zuber, M, Salman, M, Anjum, MN, Recent developments in curcumin and curcumin based 
polymeric materials for biomedical applications: A review, International Journal of Biological Macromolecules 81, 
877–890, 2015. 
[2] Mehanny, M, Hathout, RM, Geneidi, AS, Mansour, S, Exploring the use of nanocarrier systems to deliver the 
magical molecule; Curcumin and its derivatives, Journal of Controlled Release 225, 1–30, 2016. 
 
